(Total Views: 338)
Posted On: 07/27/2018 10:05:27 AM
Post# of 72446
Pete, although I would love $50B it depends on when. If we were on the market with Prurisol and revenues were $7B annually and we had 20 years protection then a BP may pay the $50B for a secure cash flow. I still think that is high.
Merck bought Cubist for $8or 9B I believe and they had a run rate of $1B in revenues.
We haven't even entered phase 3. There are no guarantees.
Maybe, maybe the whole company is worth $2-3B right now. Just my guess.
To get the big numbers we will have to partner and ride out the ups and downs.
Merck bought Cubist for $8or 9B I believe and they had a run rate of $1B in revenues.
We haven't even entered phase 3. There are no guarantees.
Maybe, maybe the whole company is worth $2-3B right now. Just my guess.
To get the big numbers we will have to partner and ride out the ups and downs.
(2)
(1)
